Elon Musk’s Neuralink, which has built the brain-computer interface (BCI), has implanted it for the first time in a human patient on Sunday. The patient is said to be recovering well.
Posting about the same on social media platform, X, on Monday, Musk wrote, “Initial results show promising neuron spike detection.” He also wrote that the first product from Neuralink would be called ‘Telepathy’.
Spikes are activity by neurons, described as cells that use electrical and chemical signals to transmit information around the brain and to the body.
The company received approval from the US Food and Drug Administration last year to carry out its first human implant trial. Neuralink said in September that it was approved to begin recruiting participants for the human trial intended for individuals with paralysis.
According to a previous statement from Neuralink, the study employs a robot to surgically implant BCI implant in a part of the brain that governs the intention to move. Its primary objective is to allow people to operate a computer cursor or keyboard with just their thoughts. The “ultra-fine” threads in the implants aid in signal transmission throughout the brain.
In order to assess the safety of the implant and surgical robot, the startup is conducting a trial for its wireless brain-computer interface called PRIME Study.
The business has been under pressure to examine its safety procedures. The US Department of Transportation (DOT) fined the company for breaking regulations pertaining to the transportation of hazardous materials, according to a report by the British news agency Reuters earlier this month.